One-pot, multicomponent synthesis of 2,3-disubstituted quinazolin-ones with potent and selective activity against Toxoplasma gondii.

[1]  L. D.,et al.  Antimicrobial Drug Resistance , 2017, Springer International Publishing.

[2]  R. Yolken,et al.  Enol ethers as carbonyl surrogates in a modification of the Povarov synthesis of 3-aryl quinolines and their anti-Toxoplasma activity. , 2016, Organic & biomolecular chemistry.

[3]  Stephanie D. Geuns-Meyer,et al.  Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity. , 2016, Journal of medicinal chemistry.

[4]  Haifeng Zhou,et al.  FeCl3-catalyzed tandem condensation/intramolecular nucleophilic addition/C–C bond cleavage: a concise synthesis of 2-substitued quinazolinones from 2-aminobenzamides and 1,3-diketones in aqueous media , 2016 .

[5]  Wei Wang,et al.  2‐Pyridinyl‐4(3H)‐Quinazolinone: A Scaffold for Anti‐influenza A Virus Compounds , 2015, Chemical biology & drug design.

[6]  P. Davis,et al.  Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity , 2015, Antimicrobial Agents and Chemotherapy.

[7]  S. Yin,et al.  Metal- and Oxidant-Free Synthesis of Quinazolinones from β-Ketoesters with o-Aminobenzamides via Phosphorous Acid-Catalyzed Cyclocondensation and Selective C-C Bond Cleavage. , 2015, The Journal of organic chemistry.

[8]  Jianmin Lu,et al.  The cascade synthesis of quinazolinones and quinazolines using an α-MnO2 catalyst and tert-butyl hydroperoxide (TBHP) as an oxidant. , 2015, Chemical communications.

[9]  Jing-Mei Yuan,et al.  Distinct novel quinazolinone exhibits selective inhibition in MGC-803 cancer cells by dictating mutant p53 function. , 2015, European journal of medicinal chemistry.

[10]  Galen P. Miley,et al.  Discovery, Synthesis, and Optimization of Antimalarial 4(1H)-Quinolone-3-Diarylethers , 2014, Journal of medicinal chemistry.

[11]  C. Cheon,et al.  Synthesis of quinazolinones from anthranilamides and aldehydes via metal-free aerobic oxidation in DMSO , 2014 .

[12]  R. Yolken,et al.  Synthesis and anti-toxoplasmosis activity of 4-arylquinoline-2-carboxylate derivatives. , 2014, Organic & biomolecular chemistry.

[13]  H. Shaterian,et al.  An efficient synthesis of quinazoline and xanthene derivatives using starch sulfate as a biodegradable solid acid catalyst , 2015, Research on Chemical Intermediates.

[14]  R. Cheng,et al.  One-Pot Synthesis of Quinazolinones from Anthranilamides and Aldehydes via p-Toluenesulfonic Acid Catalyzed Cyclocondensation and Phenyliodine Diacetate Mediated Oxidative Dehydrogenation , 2013 .

[15]  T. Zhu,et al.  Antiviral alkaloids produced by the mangrove-derived fungus Cladosporium sp. PJX-41. , 2013, Journal of natural products.

[16]  Jianguang Zhou,et al.  One-pot synthesis of quinazolinones via iridium-catalyzed hydrogen transfers. , 2011, The Journal of organic chemistry.

[17]  R. Yolken,et al.  Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii. , 2010, Journal of medicinal chemistry.

[18]  L. Goldani,et al.  Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole. , 2010, Current opinion in investigational drugs.

[19]  F. Dickerson,et al.  Toxoplasma and schizophrenia , 2009, Parasite immunology.

[20]  S. Carradori,et al.  Synthesis and evaluation of 4-acyl-2-thiazolylhydrazone derivatives for anti-Toxoplasma efficacy in vitro. , 2009, Journal of medicinal chemistry.

[21]  N. Shadjou,et al.  Synthesis of New 2-Aryl Substituted 2,3-Dihydroquinazoline-4(1H)-ones Under Solvent-Free Conditions, Using Molecular Iodine as a Mild and Efficient Catalyst , 2008 .

[22]  Latesh Lad,et al.  Mechanism of inhibition of human KSP by ispinesib. , 2008, Biochemistry.

[23]  R. Yolken,et al.  Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii , 2003, Schizophrenia Research.

[24]  S Diamond,et al.  Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors. , 2000, Journal of medicinal chemistry.

[25]  D. Lindsay,et al.  Structures of Toxoplasma gondiiTachyzoites, Bradyzoites, and Sporozoites and Biology and Development of Tissue Cysts , 1998, Clinical Microbiology Reviews.